Robertson Opportunity Capital LLC lessened its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 33.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 86,470 shares of the company’s stock after selling 43,200 shares during the period. Nu Skin Enterprises comprises about 4.4% of Robertson Opportunity Capital LLC’s investment portfolio, making the stock its 11th largest position. Robertson Opportunity Capital LLC owned approximately 0.16% of Nu Skin Enterprises worth $6,374,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of NUS. Mackay Shields LLC bought a new stake in shares of Nu Skin Enterprises in the first quarter worth $23,903,000. Old Mutual Global Investors UK Ltd. increased its stake in shares of Nu Skin Enterprises by 63.1% in the fourth quarter. Old Mutual Global Investors UK Ltd. now owns 821,316 shares of the company’s stock worth $56,038,000 after buying an additional 317,869 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of Nu Skin Enterprises in the fourth quarter worth $13,373,000. UBS Asset Management Americas Inc. increased its stake in shares of Nu Skin Enterprises by 381.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 224,985 shares of the company’s stock worth $15,351,000 after buying an additional 178,250 shares during the last quarter. Finally, OppenheimerFunds Inc. increased its stake in shares of Nu Skin Enterprises by 1,497.3% in the first quarter. OppenheimerFunds Inc. now owns 148,041 shares of the company’s stock worth $10,912,000 after buying an additional 138,773 shares during the last quarter. Institutional investors and hedge funds own 76.89% of the company’s stock.
In other news, Director Neil H. Offen sold 7,000 shares of the business’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $81.66, for a total transaction of $571,620.00. Following the completion of the transaction, the director now owns 11,267 shares of the company’s stock, valued at $920,063.22. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, General Counsel D Matthew Dorny sold 3,250 shares of the business’s stock in a transaction on Monday, April 2nd. The shares were sold at an average price of $72.22, for a total transaction of $234,715.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 109,750 shares of company stock valued at $8,259,910. 3.00% of the stock is currently owned by corporate insiders.
Nu Skin Enterprises stock opened at $82.81 on Thursday. The firm has a market capitalization of $4.51 billion, a price-to-earnings ratio of 25.64, a price-to-earnings-growth ratio of 2.74 and a beta of 1.34. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.14 and a quick ratio of 0.75. Nu Skin Enterprises, Inc. has a 12 month low of $53.50 and a 12 month high of $84.00.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, April 26th. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.09. The firm had revenue of $616.00 million during the quarter, compared to the consensus estimate of $564.46 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.36%. The firm’s revenue was up 23.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.51 earnings per share. analysts anticipate that Nu Skin Enterprises, Inc. will post 3.55 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 13th. Shareholders of record on Friday, May 25th were issued a $0.365 dividend. This represents a $1.46 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date was Thursday, May 24th. Nu Skin Enterprises’s dividend payout ratio is presently 45.20%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.